Announcements A Joint Statement on Technical, legal, ethical and implementation concerns regarding Aarogya Setu and other apps introduced during COVID-19 in India by Jan Swasthya Abhiyan (JSA), Internet Freedom Foundation (IFF), Forum for Medical Ethics Society (FMES), and All India People’s Science Network (AIPSN)   |   Submission to the National Human Rights Commission (NHRC) on behalf of Hub5 (HEaL Institute, APU, Seher-CHSJ, and IAPH) – COPASAH on human rights issues confronted by ASHAS and ANMs during the Covid-19 pandemic | Aug 7, 2020   |   Letter to MMC by FMES, PUCL-MH, FAOW, and MFC urging to restore its order suspending licenses of two doctors accused of abetting the suicide of Dr Payal Tadvi

Was the Gadchiroli trial ethical? Response from the principal investigator

Abhay Bang

DOI: 10.20529/IJME.2010.004


Abstract

In 2007, Oxford University Press published a book titled Ethical issues in international biomedical research: a casebook edited by James Lavery and others. One of the case studies presented by the editors and discussed by two discussants, Zulfiqar Bhutta and Marcia Angell, is titled ‘Evaluating home-based treatment strategies for neonatal sepsis in India`. This case study is about the field trial of home-based neonatal care (HBNC) conducted in Gadchiroli, India by us. Earlier, Prof Anthony Costello from the Institute of Child Health, London and now Sadath Sayeed from Boston have put forward some facts and arguments about the ethics of the Gadchiroli trial. As the principal investigator of that field trial, I wish to add a few things.

Full Text

HTML PDF

Keywords

N/A

Refbacks

There are currently no refbacks.

Article Views

PDF Downloads

Click here to support US